Axcella Health Inc.
AXLA · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.66 | -0.16 | 1.82 |
| FCF Yield | -24.53% | -0.58% | -3.49% | -0.83% |
| EV / EBITDA | -2.18 | -208.77 | -39.23 | -133.44 |
| Quality | ||||
| ROIC | 408.65% | -157.85% | -346.74% | -88.34% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.07 | 1.28 | 0.68 | 1.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 28.38% | 67.19% | 16.92% | -0.11% |
| Safety | ||||
| Net Debt / EBITDA | 2.20 | 2.57 | 1.37 | -0.13 |
| Interest Coverage | 0.00 | 0.00 | -28.42 | -20.64 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |